Blood and urine-based biomarkers in prostate cancer: Current advances, clinical applications, and future directions
{{output}}
Prostate cancer (PCa) is one of the most prevalent malignancies in men, characterized by high clinical and molecular heterogeneity. Despite the widespread use of prostate-specific antigen (PSA) for diagnosis and monitoring, its limited specificity and sensitiv... ...
